AC
NITE

Ascend Capital’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Ascend Capital’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-151,691
Closed -$2.43M – 239
2018
Q2 		$2.43M Buy
151,691
+30,710
+25% +$438K 0.11% 137
2018
Q1 		$1.73M Buy
+120,981
New +$1.65M 0.07% 168

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Ascend Capital's NITE Position: Q3 2018 in Review

Ascend Capital sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q3 2018, closing a stake of 151,691 shares — an estimated $2.43M sold.

Ascend Capital first reported a position in NITE in Q1 2018 and held it in 2 quarters. The position peaked at $2.43M in Q2 2018. 36 funds tracked by Wall St. Rank hold NITE as of Q3 2018.

  • Ascend Capital reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • Ascend Capital sold 151,691 Nightstar Therapeutics plc American Depositary Shares shares in Q3 2018, an estimated $2.43M.
  • Ascend Capital first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2018 and held it in 2 quarters.
  • Ascend Capital's Nightstar Therapeutics plc American Depositary Shares position peaked at $2.43M in Q2 2018.
  • 36 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.